Proven results
Controlled mean Glycosylated Hemoglobin
The average estimated* glycosylated haemoglobin of users with regular use of SocialDiabetes is 6.7% for type 1 and 6.5% for type 2.
Reduction of up to 1% of Glycosylated Hemoglobin in 3 months
Users with type 1 diabetes with a high initial glycosylated haemoglobin (HbA1c > 8%), experience, on average, a reduction of 1% after 3 months of continuous use of SocialDiabetes. In the case of users with type 2 diabetes, this reduction rises to 2%.
Join the largest community of users.
Thanks to SocialDiabetes our users ...
Have eaten more than 7 million servings of carbohydrates.
More than 141 liters of rapid insulin have been put in.
Have taken more than 205,000 pills
Awards
Best mobile application in the health category - WSA United Nations
Best Health App 2015-2019 iSYS Foundation
Winners MunichRE InsurTech Accelerator 2016
Collaborators
NextGenerationEU
PROJECT: Towards a new generation of digital diabetes solutions: Artificial pancreas for patients with continuous monitoring devices and smart pen insulin. (2022 - 2025). Reference: CPP2021-008659. Funded by MCIN - 656.441,06€. P.I. Josep Vehí. Participants: SocialDiabetes, UdG